Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
Drug Development Research · 2025-02 · 86 (1)
DOI: 10.1002/ddr.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 24.12.2024. Verfasst von Marwa I Serag und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. Hauptthemen laut MEDLINE: ErbB Receptors, Molecular Docking Simulation, Thiadiazoles, Drug Design. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
Five series of new 1,3,4‐thiadiazole hybrids were designed and synthesized as promising EGFR inhibitors. Three human cancer cell lines were employed for testing each hybrid's in vitro antiproliferative efficacy; colon HCT‐116, liver HepG‐2 and breast MCF‐7 using MTT assay. Comparing compound 9a to the reference doxorubicin, 9a shown superior activity to that of Dox with respect to MCF‐7 (IC 50 3.31 µM) while being secure for normal cells WI‐38 (IC 50 = 43.99 µM). Further evaluation of the EGFR inhibitory activity of the most active candidates— 4a, 6b , 8b, 9a , and 9 d —was performed. Of them, compounds 9a and 8b demonstrated the highest IC 50 values, 0.08 and 0.15 µM, respectively, relative to the reference gefitinib (IC 50 = 0.04 µM). Subsequent mechanistic analysis of compound 9a revealed a notable 14.24‐fold increase in overall apoptosis and a 28.92% cell cycle arrest at G2/M. Additionally, research on apoptosis demonstrated that it triggered the mitochondrial apoptotic pathway. In MCF‐7 cells, it also led to an increase in ROS buildup. For the most powerful EGFR inhibitors, 9a and 8b , a molecular docking research was conducted, and all of the findings agreed with the biological findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura National University, Gamasa, Egypt.
ORCID-Profile: Marwa I Serag
Zitieren
APA
Serag, M. I., Tawfik, S. S., Eisa, H. M., & Badr, S. M. I. (2025). Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors. Drug Development Research, 86(1). https://doi.org/10.1002/ddr.70035
Vancouver
Serag MI, Tawfik SS, Eisa HM, Badr SMI. Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors. Drug Development Research. 2025;86(1). doi:10.1002/ddr.70035
BibTeX
@article{Serag2025,
author = {Serag, Marwa I and Tawfik, Samar S and Eisa, Hassan M and Badr, Sahar M I},
title = {Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors},
journal = {Drug Development Research},
year = {2025},
volume = {86},
number = {1},
doi = {10.1002/ddr.70035}
}
EUVIMED